The Q2 23 beat was driven by healthy performances from both business segments, and the top-line benefits also percolated down to operating profitability. Moreover, the management upgraded its 2023 guidance. Overall, Alcon’s commanding position in its target markets, promising growth prospects for its offerings and improving profitability all support our positive recommendation.


Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Good Q2, guidance ‘again’ improved
The Q2 23 beat was driven by healthy performances from both business segments, and the top-line benefits also percolated down to operating profitability. Moreover, the management upgraded its 2023 guidance. Overall, Alcon’s commanding position in its target markets, promising growth prospects for its offerings and improving profitability all support our positive recommendation.